Arcadia Biosciences, Inc. (NASDAQ:RKDA – Get Free Report) was the target of a large drop in short interest in March. As of March 15th, there was short interest totalling 10,300 shares, a drop of 16.9% from the February 28th total of 12,400 shares. Based on an average daily volume of 15,000 shares, the days-to-cover ratio is currently 0.7 days. Currently, 0.8% of the shares of the stock are sold short.
Arcadia Biosciences Stock Up 2.8 %
RKDA traded up $0.08 during trading on Thursday, hitting $2.75. The company’s stock had a trading volume of 881 shares, compared to its average volume of 310,364. The stock has a market capitalization of $3.75 million, a price-to-earnings ratio of -0.64 and a beta of 0.78. The firm’s 50 day moving average price is $4.02 and its two-hundred day moving average price is $4.12. Arcadia Biosciences has a 12 month low of $1.85 and a 12 month high of $10.31.
Institutional Investors Weigh In On Arcadia Biosciences
A hedge fund recently bought a new stake in Arcadia Biosciences stock. Geode Capital Management LLC purchased a new stake in shares of Arcadia Biosciences, Inc. (NASDAQ:RKDA – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,297 shares of the basic materials company’s stock, valued at approximately $73,000. Geode Capital Management LLC owned about 0.90% of Arcadia Biosciences at the end of the most recent reporting period. Hedge funds and other institutional investors own 17.73% of the company’s stock.
Analyst Ratings Changes
View Our Latest Research Report on Arcadia Biosciences
Arcadia Biosciences Company Profile
Arcadia Biosciences, Inc produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring.
Further Reading
- Five stocks we like better than Arcadia Biosciences
- 3 Warren Buffett Stocks to Buy Now
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Big Buybacks: 3 Large Caps Exceed 5% Repurchase Power
- How to Use High Beta Stocks to Maximize Your Investing Profits
- NVIDIA vs Qualcomm: Which Is the Better Buy for Q2?
Receive News & Ratings for Arcadia Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arcadia Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.